Commercial, legal, political, and scientific trends in biotechnology
General Biotechnology
Could patients glean stock tips?: Drug trial participants may be insider trading.
Could patients glean stock tips?: Drug trial participants may be insider trading.
“Patients in clinical trials might be using information about the drug they are taking to trade illegally in pharmaceutical stocks, warns a group of doctors and bioethicists. But they have no idea how prevalent the problem might be.”
© 2004 Biotech Blog. 
Discussion
No comments for “Could patients glean stock tips?: Drug trial participants may be insider trading.”
Post a comment